Inmune Bio (INMB) Change in Receivables (2021 - 2025)
Historic Change in Receivables for Inmune Bio (INMB) over the last 5 years, with Q3 2025 value amounting to $108000.0.
- Inmune Bio's Change in Receivables rose 10530.97% to $108000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $604000.0, marking a year-over-year increase of 16175.87%. This contributed to the annual value of -$724000.0 for FY2024, which is 8831.13% up from last year.
- Per Inmune Bio's latest filing, its Change in Receivables stood at $108000.0 for Q3 2025, which was up 10530.97% from $322000.0 recorded in Q2 2025.
- In the past 5 years, Inmune Bio's Change in Receivables ranged from a high of $1.0 million in Q2 2024 and a low of -$6.2 million during Q2 2023
- Its 5-year average for Change in Receivables is -$388250.0, with a median of $87000.0 in 2024.
- Data for Inmune Bio's Change in Receivables shows a peak YoY increase of 86500.0% (in 2023) and a maximum YoY decrease of 159835.62% (in 2023) over the last 5 years.
- Inmune Bio's Change in Receivables (Quarter) stood at $403000.0 in 2021, then crashed by 38.46% to $248000.0 in 2022, then plummeted by 173.39% to -$182000.0 in 2023, then soared by 139.56% to $72000.0 in 2024, then skyrocketed by 50.0% to $108000.0 in 2025.
- Its Change in Receivables stands at $108000.0 for Q3 2025, versus $322000.0 for Q2 2025 and $102000.0 for Q1 2025.